Regeneron high-dose Eylea gains FDA approval (NASDAQ:REGN)
Iryna Drozd The US FDA has approved Regeneron Pharmaceuticals' (NASDAQ:REGN) high-dose ("HD") version of its blockbuster therapy Eylea (aflibercept). The ...
Friday, November 8, 2024
Tag: Regeneron
Regeneron Stock Sinks on Disappointing Sales of Eylea Treatment
Regeneron Pharmaceuticals stock was tumbling after the medicine maker reported lower sales of its Eylea treatment than Wall Street was ...
GameStop, Rivian, Regeneron, Snap and more
Pedestrians pass in front of a GameStop retail store in New York, December 23, 2021.Scott Mlyn | CNBCCheck out the ...
AbbVie, Roche, Regeneron may considerably profit as AMD market anticipated to soar
Marcelo Ricardo Daros AbbVie (NYSE:ABBV), Roche (OTCQX:RHHBY), and Regeneron Prescription drugs (NASDAQ:REGN), which market and/or are creating new age-related macular ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.